FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Craig Smith

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Phenomena

Recurrence

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Craig H Smith; Emmanuelle Waubant; Annette Langer-Gould
Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population.
Amit Bar-Or; Peter A Calabresi; Douglas Arnold; Douglas Arnlod; Clyde Markowitz; Stuart Shafer; Lloyd H Kasper; Emmanuelle Waubant; Suzanne Gazda; Robert J Fox; Michael Panzara; Neena Sarkar; Sunil Agarwal; Craig H Smith
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy L Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Craig Smith (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Craig H Smith; Emmanuelle Waubant; Annette Langer-Gould
Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2009;29(2):104-6.
2008: Amit Bar-Or; Peter A Calabresi; Douglas Arnold; Douglas Arnlod; Clyde Markowitz; Stuart Shafer; Lloyd H Kasper; Emmanuelle Waubant; Suzanne Gazda; Robert J Fox; Michael Panzara; Neena Sarkar; Sunil Agarwal; Craig H Smith
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Annals of neurology 2008;63(3):395-400.
2008: Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy L Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
The New England journal of medicine 2008;358(7):676-88.
2006: R Philip Kinkel; Craig Kollman; Paul O'Connor; Thomas Jock Murray; Jack Simon; Douglas Arnold; Rohit Bakshi; Bianca Weinstock-Gutman; Staley Brod; Joanna Cooper; Pierre Duquette; Eric Eggenberger; Warren Felton; Robert Fox; Mark Freedman; Steven Galetta; Andrew Goodman; Joseph Guarnaccia; Stanley Hashimoto; Steven Horowitz; Jeffrey Javerbaum; Lloyd Kasper; Michael Kaufman; Lloyd Kerson; Michele K Mass; Kottil W. Rammohan; Merrell Reiss; Loren Rolak; John Rose; Thomas Scott; John Selhorst; Robert K Shin; Craig H Smith; William Stuart; Stephen Thurston; Michael Wall
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Neurology 2006;66(5):678-84.
2005: Dennis N Bourdette; E Edmonds; Craig H Smith; J D Bowen; C R G Guttmann; Z P Nagy; J Simon; Ruth H Whitham; Jesus Lovera; Vijayshree Yadav; Michele K Mass; L Spencer; Nicole Culbertson; Richard Bartholomew; Georgia Theofan; J Milano; Halina Offner; Arthur Vandenbark
A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(5):552-61.
2004: Roy W Beck; Craig H Smith; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; edward buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A. Goodwin; Barrett D. Katz; David I Kaufman; John L Keltner; Mark Kupersmith; Neil R Miller; Pamela S Moke; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Jonathan D Trobe; Michael Wall
Neurologic impairment 10 years after optic neuritis.
Archives of neurology 2004;61(9):1386-9.
2004: Roy W Beck; Robin L Gal; M Tariq Bhatti; Michael C Brodsky; edward buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A. Goodwin; Barrett D. Katz; David I Kaufman; John L Keltner; Mark Kupersmith; Neil R Miller; Pamela S Moke; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Jonathan D Trobe; Michael Wall; Dongyuan Xing
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.
American journal of ophthalmology 2004;137(1):77-83.
2003: Roy W Beck; Jonathan D Trobe; Pamela S Moke; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; edward buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A. Goodwin; Barrett D. Katz; David I Kaufman; John L Keltner; Mark Kupersmith; Neil R Miller; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Michael Wall
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
Archives of ophthalmology 2003;121(7):944-9.
1993: S R Hamilton; Craig H Smith; Simmons Lessell
Idiopathic hypertrophic cranial pachymeningitis.
Journal of clinical neuro-ophthalmology 1993;13(2):127-34.
1982: R W Beck; P J Savino; N J Schatz; Craig H Smith; Robert Sergott
Plaque causing homonymous hemianopsia in multiple sclerosis identified by computed tomography.
American journal of ophthalmology 1982;94(2):229-34.